Open tender · Request for Proposal
Pralidoxime
Department of National Defence (DND)
- Bids close
- November 10, 2026
- November 10, 2026 at 14:00 (in 26 days)
- Published
- September 24, 2026
- Type
- Goods
- Competitive - Open bidding
- Delivery
- Anywhere in Canada
- and 1 more
CanadaBuys tender notices published since Aug 2022; open as of October 12, 2026. Source: Public Services and Procurement Canada, CanadaBuys open data.
What it is
- Reference
- cb-572-47218385 · solicitation W6369-26-A033/B
- Commodity (UNSPSC)
- 51000000 Drugs and Pharmaceutical Products
- Topic
- Drugs and pharmaceuticals
- Delivery regions
- Anywhere in Canada, Outside Canada
- Trade agreements
- Canada-Honduras Free Trade Agreement; North American Free Trade Agreement (NAFTA); Canada-Ukraine Free Trade Agreement (CUFTA); Canada-Chile Free Trade Agreement (CCFTA); Canada-European Union Comprehensive Economic and Trade Agreement (CETA); Canadian Free Trade Agreement (CFTA); Canada-Peru Free Trade Agreement (CPFTA); Canada-Colombia Free Trade Agreement; World Trade Organization Agreement on Government Procurement (WTO GPA); Canada-Korea Free Trade Agreement (CKFTA); Canada-UK Trade Continuity Agreement (Canada-UK TCA); Canada-Panama Free Trade Agreement; Comprehensive and Progressive Agreement for Trans-Pacific Partnership (CPTPP)
- How the winner is picked
- Lowest Price What this means
Excerpt of the buyer’s description, with contact details left out. The notice on CanadaBuys is the official version.
Should you bid?
What the public record says about work like this. The notice on CanadaBuys is what counts: read it before deciding.
- Who won the last one
The last award notice from National Defence for the same commodity code went to GlaxoSmithKline Inc. in Mar 2026, for $29,400,277. That contract runs to Mar 2027.
It ends within six months of this one starting, so this tender may be its replacement, and that supplier the incumbent. Incumbents know the work and the buyer; check the notice for whether the scope changed.
- What work like this goes for
Half of the 80 award notices for the same commodity code were between $329,750 and $12,521,608; the middle one was $2,106,590. Values as awarded, in Canadian dollars, and often including option years.
- How many bids to expect
National Defence’s competitive contracts of $25,000 or more since Apr 2022 drew a median of 1 bid; 89% drew a single bid (1,349 contracts).
Bid counts as the department reported them to the Treasury Board. Departments count differently, so compare within one buyer, not across buyers.
- How this buyer buys
Of National Defence’s 143 contracts for drugs and pharmaceuticals since Apr 2022, 7% were non-competitive and 44% were call-ups against standing offers or supply arrangements, which only firms already on those lists can win. How to get on them
- Room for smaller firms
27% of the 62 award notices for the same commodity class went to suppliers with under $1 million in federal contracts since Jan 2004.
Sources: CanadaBuys award notices since Aug 2022 (October 12, 2026); Treasury Board contracts data, bid counts from Apr 2022 on (October 13, 2026). Buyers are matched by name; Crown corporations such as Defence Construction Canada are not in the Treasury Board data.
New to bidding? How to bid on federal contracts · Get help with a bid
Who won the last ones like it
Recent CanadaBuys award notices with the same commodity code.
| Awarded | Supplier | What | Buyer | Value |
|---|---|---|---|---|
| Aug 2026 | Emergent BioSolutions Canada Inc. | SO - Naloxone Nasal Spray - Emergent BioSolutions Canada Inc | Royal Canadian Mounted Police (RCMP) | $3,000,000 |
| Apr 2026 | McKesson Canada Corporation | 21120-268734 Cystic Fibrosis Medications NISO | Correctional Service of Canada (CSC) | $4,000,000 |
| Apr 2026 | PRAXES Medical Group | K4E21-260484 REMOTE MEDICAL HEALTH CARE SUPPORT WITH MEDICAL SUPPLY KITS | Department of the Environment (ECCC ) | $79,147 |
| Apr 2026 | GlaxoSmithKline Inc. | Hepatitis B Vaccines GSK | Department of Public Works and Government Services (PSPC) | $9,462,827 |
| Apr 2026 | Merck Canada Inc. | Hepatitis B Vaccines Merck | Department of Public Works and Government Services (PSPC) | $3,855,797 |
| Mar 2026 | GlaxoSmithKline Inc. | Contract (GSK) - Supply Pertussis-containing vaccines | Department of National Defence (DND); Correctional Service of Canada (CSC); Department of Health (HC) | $29,400,277 |
| Mar 2026 | Sanofi Pasteur Limited/Sanofi Pasteur Limitee | Contract (Sanofi) - Supply Pertussis-containing vaccines | Correctional Service of Canada (CSC); Department of Health (HC); Department of National Defence (DND) | $37,781,553 |
| Feb 2026 | Emergent Product Development Gaithersburg Inc | ACAM2000-2nd Generation Smallpox Vaccine | Public Health Agency of Canada (PHAC) | $34,175,344 |
| Feb 2026 | Emergent BioDefense Operations Lansing | Tembexa (brincidofovir) Smallpox antiviral | Public Health Agency of Canada (PHAC) | $12,148,810 |
| Feb 2026 | GlaxoSmithKline Inc. | Meningococcal B Vaccine 2026 - GSK | Department of Public Works and Government Services (PSPC) | $3,147,955 |
| Oct 2025 | Not named here | Public Health Agency of Canada (PHAC) | $486,840 | |
| Jun 2025 | Moderna Biopharma Canada Corporation | COVID-19 Vaccines | Department of Public Works and Government Services (PSPC) | $360,542,980 |
| Jun 2025 | Pfizer Canada ULC | COVID-19 Vaccines | Department of Public Works and Government Services (PSPC) | $218,379,736 |
| May 2025 | Emergent BioSolutions Canada | 6D012-247322 - Vendor Managed - 3 Streams | Public Health Agency of Canada (PHAC) | $351,000 |
| May 2025 | Biogénesis Bagó S.A. | Foot and Mouth Disease Vaccine Bank | Canadian Food Inspection Agency (CFIA) | $9,397,000 |
Values as awarded, from $79,147 to $360,542,980.
Who wins most in this commodity class
Suppliers with the most award notices in the same six-digit UNSPSC class since 2022. Notices that give no value count in Awards, not in Total.
| Supplier | Awards | Total |
|---|---|---|
| GlaxoSmithKline Inc. | 7 | $128M |
| Emergent BioSolutions Canada Inc. | 5 | $85.4M1 not stated |
| Merck Canada Inc. | 4 | $370M |
| Pharmascience Inc. | 4 | $4.3M |
| Sanofi Pasteur Limited/Sanofi Pasteur Limitee | 3 | $79.6M |
| Natco Pharma (Canada) Inc. | 3 | $23.2M |
| Sandoz Canada Inc. | 3 | $5.7M |
| Pfizer Canada ULC | 2 | $258M |
| Emergent Product Development Gaithersburg Inc | 2 | $87.5M |
| HEYL Chem.-pharm. Fabrik GmbH & Co. KG | 2 | $19.9M |
CanadaBuys award notices since Aug 2022. They overlap the Treasury Board contract figures and are never added to them. Source: CanadaBuys open data, October 12, 2026.